- Home
- EXAS vs HMY Comparison
EXAS vs HMY Comparison
Compare EXAS & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- HMY
- Stock Information
- Founded
- EXAS 1995
- HMY 1950
- Country
- EXAS United States
- HMY South Africa
- Employees
- EXAS N/A
- HMY N/A
- Industry
- EXAS Medical Specialities
- HMY Precious Metals
- Sector
- EXAS Health Care
- HMY Basic Materials
- Exchange
- EXAS Nasdaq
- HMY Nasdaq
- Market Cap
- EXAS 9.1B
- HMY 8.7B
- IPO Year
- EXAS N/A
- HMY N/A
- Fundamental
- Price
- EXAS $45.60
- HMY $15.43
- Analyst Decision
- EXAS Strong Buy
- HMY Hold
- Analyst Count
- EXAS 22
- HMY 2
- Target Price
- EXAS $66.43
- HMY $12.20
- AVG Volume (30 Days)
- EXAS 3.9M
- HMY 3.4M
- Earning Date
- EXAS 08-06-2025
- HMY 01-01-0001
- Dividend Yield
- EXAS N/A
- HMY 0.90%
- EPS Growth
- EXAS N/A
- HMY 16.30
- EPS
- EXAS N/A
- HMY 0.88
- Revenue
- EXAS $2,939,949,000.00
- HMY $3,553,951,394.00
- Revenue This Year
- EXAS $14.61
- HMY $22.58
- Revenue Next Year
- EXAS $12.71
- HMY $21.51
- P/E Ratio
- EXAS N/A
- HMY $17.17
- Revenue Growth
- EXAS 12.55
- HMY 16.84
- 52 Week Low
- EXAS $38.81
- HMY $7.97
- 52 Week High
- EXAS $72.83
- HMY $18.77
- Technical
- Relative Strength Index (RSI)
- EXAS 44.47
- HMY 56.95
- Support Level
- EXAS $40.55
- HMY $15.05
- Resistance Level
- EXAS $45.45
- HMY $15.72
- Average True Range (ATR)
- EXAS 2.04
- HMY 0.41
- MACD
- EXAS 0.07
- HMY 0.06
- Stochastic Oscillator
- EXAS 63.10
- HMY 72.47
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.